Intended Use

The uMR Omega system is indicated for use as a magnetic resonance diagnostic device (MRDD) producing sagittal, transverse, coronal, and oblique cross-sectional and spectroscopic images to display anatomical structure and function of the head, body, and extremities. It supports diagnosis when interpreted by a trained physician, with optional contrast agent use depending on scan region.

Technology

The device is a 3.0T superconducting MRI system with a 75 cm bore and a comprehensive set of RF coils including new coils with increased element counts for better coverage. Software includes advanced pulse sequences, AI-assisted compressed sensing, deep learning image reconstruction (DeepRecon), image stitching, dynamic studies, fusion, spectroscopy, cardiac analysis, and other post-processing tools. The software runs as a stand-alone solution or integrated with UIH MRI scanners.

Performance

Performance testing included clinical evaluations in a diverse U.S. population with multiple imaging protocols and body parts, bench and software validation of advanced features such as DeepRecon AI reconstruction, spectroscopy sequences, cardiac mapping, and artifact reduction. The device met acceptance criteria for signal-to-noise ratio, uniformity, contrast, and structural measurements. Safety and biocompatibility testing were also conducted per relevant international standards.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    2/4/2022

    8 months
  • 2

    FDA Approval

    10/27/2022

Other devices from Shanghai United Imaging Healthcare Co.,Ltd.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.